2015-2017 ACBS Child Combined Prevalence Tables

Table 7

Estimated percent using an inhaled corticosteroid in the past 3 months among children 1 with current 2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2015-2017.

Table 7: BRFSS Asthma Call-Back survey 2015-2017
State/Territory Current
Sample
size±
% SE§ 95% CI
California 101 25.4 4.8 (16.0 – 34.8)
Connecticut 152 31.0 5.0 (21.2 – 40.8)
Florida 229 19.0 5.4 (8.4 – 29.6)
Georgia 100 16.1 3.5 (9.2 – 23.0)
Hawaii 82 24.7 6.1 (12.7 – 36.7)
Indiana 124 31.3 6.3 (19.0 – 43.6)
Kansas 245 38.4 3.9 (30.8 – 46.0)
Maine 132 20.5 4.3 (12.1 – 28.9)
Michigan 192 32.0 4.3 (23.6 – 40.4)
Minnesota 228 29.4 4.1 (21.4 – 37.4)
Missouri 68 29.4 7.9 (13.9 – 44.9)
Montana 72 28.9 8.3 (12.6 – 45.2)
Nebraska 197 33.9 5.4 (23.3 – 44.5)
New Jersey 202 25.4 5.5 (14.6 – 36.2)
New Mexico 105 40.9 7.2 (26.8 – 55.0)
New York 95 25.0 6.1 (13.0 – 37.0)
Ohio 157 14.3 3.5 (7.4 – 21.2)
Oregon 68 39.0 8.0 (23.3 – 54.7)
Pennsylvania 85 34.6 7.7 (19.5 – 49.7)
Rhode Island 69 30.3 6.8 (17.0 – 43.6)
Utah 191 34.1 4.6 (25.1 – 43.1)
Vermont 81 36.5 7.0 (22.8 – 50.2)
Wisconsin 42 N/A N/A (N/A – N/A)
Puerto Rico 143 17.9 4.3 (9.5 – 26.3)
24 States / Area 3,160 25.9 1.5 (23.0 – 28.8)
Median 29.4
Range 14.3-40.9

1 Aged < 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2017/pdf/sdq_report_acbs_17-508.pdfpdf iconpdf icon